glp-1 drugs cancer Research Reveals Potential Risks of Popular Medications for Some with Neuroendocrine GLP-1 drugs linked to lower
Description
Among patients with UC, those treated with GLP1RA had lower rates of corticosteroid use (46.6% vs 85.1%), hospitalization (40.9% vs 65.9%), intestinal resection (6.52% vs 20.8%), and mortality (4.6% vs 22%) compared with controls
Obesity Rev
A large cross-sectional study by Toft-Nielsen et al
[DOI] [PubMed] [Google Scholar] 348.Trapp S., Hisadome K
As discussed below, the development of unimolecular multi-agonists that stimulate GLP-1 receptors and other receptors such as GIP receptors and glucagon receptors (GCGR) can have beneficial effects on metabolism and increase metabolic rate at tolerable doses [57]
Its ability to work synergistically with GLP-1and possibly glucagonmakes it a powerful tool for treating obesity, insulin resistance, and type 2 diabetes
